Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin k in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial☆
暂无分享,去创建一个
[1] J. Douketis,et al. Treatment of warfarin-associated coagulopathy: a physician survey. , 2001, Chest.
[2] J. Douketis,et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial , 2000, The Lancet.
[3] D. Witt,et al. Randomized, Placebo‐Controlled Trial of Oral Phytonadione for Excessive Anticoagulation , 2000, Pharmacotherapy.
[4] D. Singer,et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. , 2000, Archives of internal medicine.
[5] R. Kumar,et al. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. , 1999, Archives of internal medicine.
[6] Robert H. Nee,et al. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. , 1999, The American journal of cardiology.
[7] M. Crowther,et al. Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin , 1998, Thrombosis and Haemostasis.
[8] D. Malone,et al. Evaluation of excessive anticoagulation in a group model health maintenance organization. , 1998, Archives of internal medicine.
[9] J. Glover,et al. Conservative treatment of overanticoagulated patients. , 1995, Chest.
[10] E. Garelli,et al. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[11] L Goldman,et al. Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions. , 1989, The American journal of medicine.